Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


APPLICATION SITE DRYNESS side effect

What is APPLICATION SITE DRYNESS ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   APPLICATION SITE DRYNESS and Recently Reported Side Effects   APPLICATION SITE DRYNESS and 15 most Active Side Effect polls   APPLICATION SITE DRYNESS and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with APPLICATION SITE DRYNESS

ABREVA  ARIXTRA  CAPZASIN  CLIMARA  DURAGESIC  FENTANYL  NEUPRO  OXYTROL  ROGAINE  


Arixtra Side Effects Report #5615146-X
Consumer or non-health professional from UNITED STATES reported ARIXTRA problem on Oct 31, 2007. Male patient, 56 years of age, was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: application site dryness, injection site pain, . ARIXTRA dosage: unknown. During the same period patient was treated with DIGOXIN, REGLAN, ZOFRAN, HYDROMORPHONE. Patient recovered.

Duragesic Side Effects Report #5578810-7
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2007. Female patient, weighting 180.0 lb, was diagnosed with fibromyalgia, sleep disorder, anxiety, breakthrough pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site dryness, asthma, diabetes mellitus, dizziness, dry eye, gastrooesophageal reflux disease, muscle spasms, nausea, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, SEROQUEL, LAMICTAL, CLONAZEPAM, ACETAMINOPHEN AND OXYCODONE. Patient was hospitalized. Patient recovered.

Duragesic Side Effects Report #5570615-6
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on Dec 11, 2007. Female patient, weighting 270.0 lb, was diagnosed with pain, muscle spasms, breakthrough pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site dryness, application site erythema, application site ulcer, arthritis, meniere's disease, muscle spasms, stomach discomfort, . DURAGESIC dosage: unknown. During the same period patient was treated with CYCLOBENZAPRINE, ESTRACE, LORTAB, CYMBALTA. Patient recovered.

Abreva Side Effects Report #5461477-6
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 20, 2006. Female patient, 67 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site dryness, oral herpes, . ABREVA dosage: unknown. Patient recovered.


Abreva Side Effects Report #5462006-3
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Apr 12, 2007. Female patient, 74 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site dryness, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462021-X
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Female patient, 25 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site dryness, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462192-5
Consumer or non-health professional from UNITED STATES reported ABREVA problem on May 18, 2007. Female patient, 36 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site dryness, application site scar, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462533-9
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2007. Female patient, 86 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site dryness, application site erythema, application site pain, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462591-1
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Feb 06, 2007. Female patient, 43 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site dryness, application site reaction, . ABREVA dosage: unknown. Patient recovered.


Abreva Side Effects Report #5462697-7
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 23, 2007. Female patient, 22 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site dryness, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462752-1
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Mar 06, 2007. Female patient, 36 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site dryness, application site pain, application site swelling, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Rogaine Side Effects Report #5461043-2
ROGAINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2006. Male patient, 37 years of age, weighting 185.0 lb, was diagnosed with alopecia and was treated with ROGAINE. After drug was administered, patient experienced the following problems/side effects: application site dryness, chest pain, heart rate increased, oedema peripheral, . ROGAINE dosage: 1 ML, ONCE A DAY TOPICAL. Patient recovered.

Climara Side Effects Report #5778184-2
Consumer or non-health professional from UNITED STATES reported CLIMARA problem on Apr 18, 2008. Female patient, 50 years of age, was diagnosed with hypertension, anxiety and was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site dryness, . CLIMARA dosage: unknown. During the same period patient was treated with ANTI. Patient recovered.

Duragesic Side Effects Report #5749290-3
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on May 16, 2008. Male patient, weighting 260.0 lb, was diagnosed with pain, blood pressure, neuralgia and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site dryness, application site exfoliation, application site irritation, application site pruritus, application site reaction, breakthrough pain, type 2 diabetes mellitus, . DURAGESIC dosage: unknown. During the same period patient was treated with ATENOLOL, ENALAPRIL MALEATE, LASIX, NORVASC, GABAPENTIN, INDOMETHACIN. Patient recovered.


Neupro Side Effects Report #5708749-5
Consumer or non-health professional from GERMANY reported NEUPRO problem on Apr 07, 2008. Male patient was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site dryness, application site erythema, application site exfoliation, application site pruritus, application site scar, application site vesicles, open wound, . NEUPRO dosage: 4 MG/24H (4 MG/24H 1 IN 1 DAY (S)) TRANSDERMAL. Patient recovered.

Fentanyl Side Effects Report #5287954-9
FENTANYL TRANSDERMAL SYSTEM problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2007. Female patient, weighting 96.01 lb, was diagnosed with pain, depression, breast cancer, thyroid disorder, anxiety, sleep disorder and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site dryness, application site erythema, knee deformity, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with OXYCODONE, DILAUDID, REMERON, FEMARA, SYNTHROID, XANAX, AMBIEN. Patient was hospitalized. Patient recovered.

Abreva Side Effects Report #5461845-2
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Dec 29, 2006. Female patient, 48 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site dryness, application site irritation, application site paraesthesia, application site scab, cheilitis, hypersensitivity, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5461952-4
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 16, 2007. Female patient, 46 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site dryness, application site erythema, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5461958-5
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Jan 17, 2007. Female patient, 51 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site dryness, oral herpes, . ABREVA dosage: unknown. Patient recovered.


Abreva Side Effects Report #5461989-5
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 10, 2007. Male patient, 31 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site dryness, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462109-3
Consumer or non-health professional from UNITED STATES reported ABREVA problem on May 02, 2007. Female patient, 60 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site dryness, application site swelling, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462252-9
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2007. Female patient, 46 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site dryness, application site pain, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462353-5
Consumer or non-health professional from UNITED STATES reported ABREVA problem on July 05, 2007. Female patient, 37 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site dryness, application site scab, lip pain, lip swelling, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462592-3
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2007. Female patient, 32 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site dryness, application site irritation, application site paraesthesia, application site reaction, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462615-1
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Feb 08, 2007. Male patient, 26 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site dryness, application site exfoliation, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462806-X
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2007. Female patient, 31 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site dryness, application site exfoliation, . ABREVA dosage: unknown. Patient recovered.

Oxytrol Side Effects Report #5277216-8
Pharmacist from UNITED STATES reported OXYTROL problem on Mar 22, 2007. Female patient, 59 years of age, weighting 205.0 lb, was diagnosed with urinary incontinence and was treated with OXYTROL. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site dryness, . OXYTROL dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462636-9
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2007. Female patient, 81 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site discolouration, application site dryness, application site pain, application site reaction, . ABREVA dosage: unknown. Patient recovered.

Capzasin Side Effects Report #5736369-5
Consumer or non-health professional from UNITED STATES reported CAPZASIN NO MESS APPLICATOR problem on May 09, 2008. Female patient, 37 years of age, weighting 130.0 lb, was diagnosed with arthralgia, myalgia and was treated with CAPZASIN NO MESS APPLICATOR. After drug was administered, patient experienced the following problems/side effects: application site burn, application site discolouration, application site dryness, application site exfoliation, application site pain, application site reaction, application site scar, application site vesicles, fear, . CAPZASIN NO MESS APPLICATOR dosage: unknown. During the same period patient was treated with CAPZASIN NO MESS APPLICATOR. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about APPLICATION SITE DRYNESS side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about APPLICATION SITE DRYNESS